Plaque Psoriasis Market Size, Trends, and Growth Forecast 2026-2033

The plaque psoriasis market is witnessing dynamic shifts driven by advancements in biologics and increasing patient awareness worldwide. As innovative therapies gain traction, the market landscape is evolving with growing demand for targeted treatments, influencing industry size and market revenue significantly.

Market Size and Overview

The plaque psoriasis market is estimated to be valued at USD 32.28 Bn in 2025 and is expected to reach USD 52.17 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032.

This robust market growth is fueled by rising prevalence of psoriasis, expanded treatment options, and increasing insurance coverage in emerging economies. The Plaque Psoriasis Market Report highlights expanding market share for biologic drugs within market segments, positioning them as significant contributors to overall market revenue.

Market Drivers

- Rising Demand for Biologic Therapies
One of the key market drivers shaping the plaque psoriasis market trends is the increased uptake of biologic therapies, which offer targeted immune modulation with improved safety profiles. For instance, in 2024, the adoption rate of biologics grew by approximately 15% globally, driven by AbbVie Inc.’s Humira and new entrants like Eli Lilly’s innovative pipeline products. Market research indicates this shift is expanding market opportunities, especially among moderate to severe plaque psoriasis patients who previously had limited alternatives.

PEST Analysis

- Political: In 2024, several governments increased healthcare spending focused on chronic skin conditions, influencing reimbursement policies and market growth strategies for plaque psoriasis drugs.

- Economic: Recovery from global economic disruptions has resulted in growing disposable income in key regions, supporting enhanced patient access to advanced therapies and positively impacting market revenue.

- Social: Heightened patient awareness about psoriasis and stigma reduction campaigns in 2025 have accelerated diagnosis rates, expanding market scope and demand.

- Technological: Breakthroughs in biologics and biosimilars, including advanced drug delivery systems launched in late 2024, have refined treatment efficacy, setting new market dynamics and competitive benchmarks.

Promotion and Marketing Initiative

Pharmaceutical companies have intensified patient-centric marketing initiatives to expand their market share. For example, in 2025, Novartis International AG launched a digital awareness campaign highlighting the benefits of its psoriasis treatments, which resulted in a 20% increase in patient engagement and boosted prescription volumes. These contemporary marketing strategies play a crucial role in enhancing market visibility and driving sustained business growth.

Key Players

- AbbVie Inc.
- Novartis International AG
- Johnson & Johnson (Janssen Pharmaceuticals)
- Eli Lilly and Company
- Amgen Inc.

Recent strategic moves include:

- AbbVie Inc.’s expansion of its biosimilar portfolio in 2025, increasing market penetration in Europe with significant revenue growth.
- Novartis introduced a next-generation biologic for plaque psoriasis in early 2025, contributing to a 10% rise in its global market revenue share.
- Johnson & Johnson strengthened partnerships with biotech firms in 2024 to accelerate pipeline development, enhancing competitive positioning.
- Eli Lilly expanded clinical trial programs in emerging markets in 2025, unlocking new market segments.
- Amgen secured regulatory approval for a novel psoriasis biologic in 2024, propelling regional business growth and improving industry share.

FAQs

1. Who are the dominant players in the plaque psoriasis market?
Key market companies include AbbVie Inc., Novartis International AG, Johnson & Johnson (Janssen Pharmaceuticals), Eli Lilly and Company, and Amgen Inc., all leading market growth strategies through product innovation and strategic expansions.

2. What will be the size of the plaque psoriasis market in the coming years?
The market size is projected to reach USD 52.17 billion by 2033, growing at a CAGR of 7.1% from 2026, indicating strong market growth and expanding market revenue.

3. Which market segments present the largest growth opportunities?
Biologic therapies hold the largest growth opportunity due to their efficacy and safety, with increasing adoption especially in regions with improving healthcare infrastructure.

4. How will market development trends evolve over the next five years?
Market trends suggest a shift towards personalized medicine, enhanced drug delivery methods, and increased investment in biosimilars, augmenting market scope and competitive dynamics.

5. What is the nature of the competitive landscape and challenges in the plaque psoriasis market?
The competitive landscape is marked by intense innovation and strategic collaborations, with market restraints including high treatment costs and regulatory challenges impacting market growth.

6. What go-to-market strategies are commonly adopted in the plaque psoriasis market?
Companies frequently employ digital awareness campaigns, patient support programs, and partnerships with healthcare providers to increase market share and foster business growth.

Author Bio:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc

Article source: https://article-realm.com/article/Health-Fitness/84595-Plaque-Psoriasis-Market-Size-Trends-and-Growth-Forecast-2026-2033.html